NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

不孕治療市場成長機會、成長預測 (2020-2027年):治療、提供區分、終端用戶、各地區

Fertility Services Market by Procedure, Service, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 1009308
出版日期 內容資訊 英文 206 Pages
商品交期: 2-3個工作天內
價格
不孕治療市場成長機會、成長預測 (2020-2027年):治療、提供區分、終端用戶、各地區 Fertility Services Market by Procedure, Service, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2021年04月01日內容資訊: 英文 206 Pages
簡介

全球不孕治療的市場規模在預測期間內預計以15.9%的年複合成長率發展,從2019年的203億8861萬美元,成長到2027年257億964萬美元的規模。

全球不孕治療的市場,由於不孕症的發生率高,女性妊娠延遲的趨勢,不孕治療技術的進步,配子提供率的上升等,今後預計大幅成長。再加上對不孕的認識高漲,不孕治療的可用性,可支配所得增加,有利的診療報酬制度等要素也促進該市場的成長。

本報告提供全球不孕治療的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,市場規模的變化、預測,治療、提供區分、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特的五力分析
  • 法律規章
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • COVID-19的影響
  • 不孕治療中心數

第4章 市場分析、預測:各治療

  • 顯微授精 (ICSI)
  • 人工授精 (IUI)
  • 體外受精 (IVF)
  • 代理母親生產
  • 其他
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測

第5章 市場分析、預測:各提供種類

  • 市場規模、預測
  • 新鮮非捐贈者
  • 冷凍非捐贈者
  • 卵子、胚銀行
  • 新鮮捐贈者
  • 冷凍捐贈者

第6章 市場分析、預測:各終端用戶

  • 市場規模、預測
  • 不孕治療診所
  • 醫院
  • 外科中心
  • 臨床研究機關

第7章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各國
    • 市場規模、預測:各治療
    • 市場規模、預測:各提供種類
    • 市場規模、預測:各終端用戶

第8章 企業簡介

  • APOLLO HOSPITALS ENTERPRISE LTD.
  • CARE FERTILITY GROUP LTD.
  • CAROLINAS FERTILITY INSTITUTE
  • CITY FERTILITY
  • FERTILITY ASSOCIATES LIMITED
  • GENEA LIMITED
  • MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
  • MONASH IVF GROUP LIMITED
  • PROGYNY INC.
  • VIRTUS HEALTH
目錄
Product Code: LI_184557 / A04206

The global fertility services market generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.

Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which aid couples with infertility problems, single mothers, and the lesbian, gay, bisexual and trans (LGBT) community to procreate.

The global fertility services market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and increased rate of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.

Recent innovations in IVF technology, such as embryoscope and capsule IVF, are projected to boost the demand for fertility devices in the future. However, strenuous maintenance issues, high cost of devices; multiple pregnancies, i.e., the delivery of twins, triplets, and others, associated with fertility treatments; and ethical considerations are projected to hinder the market growth. Moreover, rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in future. In addition, rise in fertility tourism is expected to provide ample growth opportunities especially in the developing economies.

The global fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI (intracytoplasmic sperm injection), intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the fertility services market, and the current trends and future estimations to elucidate the imminent investment pockets
  • It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the market based on procedures, services, and end users assists to understand the trends in the industry
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market

KEY MARKET SEGMENTS

By Procedure

  • IVF with ICSI
  • IUI
  • IVF without ICSI
  • Surrogacy
  • Others

By Service

  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Apollo Hospitals Enterprise Ltd
  • Care Fertility Group Ltd
  • Carolinas Fertility Institute
  • City Fertility
  • Fertility Associates Limited
  • Genea Limited
  • Medicover Group
  • Monash IVF Group Limited
  • Progyny Inc.
  • Virtus Health

List of other players in the value chain (profiles not included in the report):

  • INVO Bioscience
  • IVFtech ApS

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Government regulations
    • 3.4.1.U.S.
    • 3.4.2.Europe
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Continuous decline in fertility rates
      • 3.5.1.2.Delayed pregnancies in women
      • 3.5.1.3.Technological advancements with respect to fertility treatment
    • 3.5.2.Restraints
      • 3.5.2.1.High treatment costs of ARTs in developed countries
      • 3.5.2.2.Inadequate reimbursement policies
    • 3.5.3.Opportunity
      • 3.5.3.1.Rise in fertility tourism
  • 3.6.COVID-19 impact on the fertility services market
  • 3.7.Number of fertility service centers

CHAPTER 4:FERTILITY SERVICES MARKET, BY PROCEDURE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.IVF with ICSI
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast
  • 4.3.IUI
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
  • 4.4.IVF without ICSI
    • 4.4.1.Key market trends growth factors, and opportunities
    • 4.4.2.Market size and forecast
  • 4.5.Surrogacy
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast
  • 4.6.Others
    • 4.6.1.Key market trends, growth factors, and opportunities
    • 4.6.2.Market size and forecast

CHAPTER 5:FERTILITY SERVICES MARKET, BY SERVICE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Fresh non-donor
    • 5.2.1.Market size and forecast
  • 5.3.Frozen non-donor
    • 5.3.1.Market size and forecast
  • 5.4.Egg & embryo banking
    • 5.4.1.Market size and forecast
  • 5.5.Fresh donor
    • 5.5.1.Market size and forecast
  • 5.6.Frozen donor
    • 5.6.1.Market size and forecast

CHAPTER 6:FERTILITY SERVICES MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Fertility clinics
    • 6.2.1.Market size and forecast
  • 6.3.Hospitals
    • 6.3.1.Market size and forecast
  • 6.4.Surgical centers
    • 6.4.1.Market size and forecast
  • 6.5.Clinical research institutes
    • 6.5.1.Market size and forecast

CHAPTER 7:FERTILITY SERVICES MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
    • 7.2.3.Market size and forecast, by procedure
    • 7.2.4.Market size and forecast, by service
    • 7.2.5.Market size and forecast, by end user
      • 7.2.5.1.U.S. market size and forecast, by procedure
      • 7.2.5.2.U.S. Market size and forecast, by service
      • 7.2.5.3.U.S. Market size and forecast, by end user
      • 7.2.5.4.Canada size and forecast, by procedure
      • 7.2.5.5.Canada Market size and forecast, by service
      • 7.2.5.6.Canada Market size and forecast, by end user
      • 7.2.5.7.Mexico market size and forecast, by procedure
      • 7.2.5.8.Mexico Market size and forecast, by service
      • 7.2.5.9.Mexico Market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe Market size and forecast, by country
    • 7.3.3.Europe Market size and forecast, by procedure
    • 7.3.4.Europe market size and forecast, by service
    • 7.3.5.Europe market size and forecast, by end user
      • 7.3.5.1.Germany market size and forecast, by procedure
      • 7.3.5.2.Germany market size and forecast, by service
      • 7.3.5.3.Germany market size and forecast, by end user
      • 7.3.5.4.France market size and forecast, by procedure
      • 7.3.5.5.France market size and forecast, by service
      • 7.3.5.6.France market size and forecast, by end user
      • 7.3.5.7.UK market size and forecast, by procedure
      • 7.3.5.8.UK market size and forecast, by service
      • 7.3.5.9.UK market size and forecast, by end user
      • 7.3.5.10.Italy market size and forecast, by procedure
      • 7.3.5.11.Italy Market size and forecast, by service
      • 7.3.5.12.Italy market size and forecast, by end user
      • 7.3.5.13.Spain market size and forecast, by procedure
      • 7.3.5.14.Spain Market size and forecast, by service
      • 7.3.5.15.Spain Market size and forecast, by end user
      • 7.3.5.16.Russia market size and forecast, by procedure
      • 7.3.5.17.Russia Market size and forecast, by service
      • 7.3.5.18.Russia market size and forecast, by end user
      • 7.3.5.19.Rest of Europe market size and forecast, by procedure
      • 7.3.5.20.Rest of Europe market size and forecast, by service
      • 7.3.5.21.Rest of Europe market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
    • 7.4.3.Asia-Pacific market size and forecast, by procedure
    • 7.4.4.Asia-Pacific market size and forecast, by service
    • 7.4.5.Asia-Pacific market size and forecast, by end user
      • 7.4.5.1.Japan market size and forecast, by procedure
      • 7.4.5.2.Japan market size and forecast, by service
      • 7.4.5.3.Japan market size and forecast, by end user
      • 7.4.5.4.India market size and forecast, by procedure
      • 7.4.5.5.India Market size and forecast, by service
      • 7.4.5.6.India market size and forecast, by end user
      • 7.4.5.7.China market size and forecast, by procedure
      • 7.4.5.8.China Market size and forecast, by service
      • 7.4.5.9.China Market size and forecast, by end user
      • 7.4.5.10.Australia market size and forecast, by procedure
      • 7.4.5.11.Australia Market size and forecast, by service
      • 7.4.5.12.Australia Market size and forecast, by end user
      • 7.4.5.13.South Korea market size and forecast, by procedure
      • 7.4.5.14.South Korea market size and forecast, by service
      • 7.4.5.15.South Korea market size and forecast, by end user
      • 7.4.5.16.Rest of Asia-Pacific market size and forecast, by procedure
      • 7.4.5.17.Rest of Asia-Pacific Market size and forecast, by service
      • 7.4.5.18.Rest of Asia-Pacific market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
    • 7.5.3.LAMEA market size and forecast, by procedure
    • 7.5.4.LAMEA market size and forecast, by service
    • 7.5.5.LAMEA market size and forecast, by end user
      • 7.5.5.1.Latin America market size and forecast, by procedure
      • 7.5.5.2.Latin America market size and forecast, by service
      • 7.5.5.3.Latin America market size and forecast, by end user
      • 7.5.5.4.Middle East market size and forecast
      • 7.5.5.5.Middle East market size and forecast, by service
      • 7.5.5.6.Middle East market size and forecast, by end user
      • 7.5.5.7.Africa market size and forecast
      • 7.5.5.8.Africa market size and forecast, by service
      • 7.5.5.9.Africa market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.APOLLO HOSPITALS ENTERPRISE LTD.
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.CARE FERTILITY GROUP LTD.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Key strategic moves and developments
  • 8.3.CAROLINAS FERTILITY INSTITUTE
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
  • 8.4.CITY FERTILITY
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Key strategic moves and developments
  • 8.5.FERTILITY ASSOCIATES LIMITED
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
  • 8.6.GENEA LIMITED
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Key strategic moves and developments
  • 8.7.MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.roduct portfolio
    • 8.7.5.Business performance
  • 8.8.MONASH IVF GROUP LIMITED
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.PROGYNY INC.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
    • 8.9.6.Key strategic moves and developments
  • 8.10.VIRTUS HEALTH
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW
  • TABLE 02.GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 03.FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 09.FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 15.FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 21.NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 22.NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 23.NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 24.U.S. FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 25.U.S. FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 26.U.S. FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 27.CANADA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 28.CANADA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 29.CANADA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 30.MEXICO FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 33.EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 34.EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 35.EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 36.EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 37.GERMANY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 38.GERMANY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 39.GERMANY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 40.FRANCE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 41.FRANCE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 42.FRANCE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 43.UK FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 44.UK FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 45.UK FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 46.ITALY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 47.ITALY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 48.ITALY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 49.SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 50.SPAIN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 51.SPAIN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 52.RUSSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 53.RUSSIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 54.RUSSIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 55.REST OF EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 56.REST OF EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 57.REST OF EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 58.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 59.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 60.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 61.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 62.JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 63.JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 64.JAPAN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 65.INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 66.INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 67.INDIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 68.CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 69.CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 70.CHINA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 71.AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 72.AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 73.AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 74.SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 75.SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 76.SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 77.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 78.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 79.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 80.LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 81.LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 82.LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 83.LAMEA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 84.LATIN AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 85.LATIN AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 86.LATIN AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 87.MIDDLE EAST FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 88.MIDDLE EAST FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 89.MIDDLE EAST FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 90.AFRICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
  • TABLE 91.AFRICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
  • TABLE 92.AFRICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 93.APOLLO HOSPITALS: COMPANY SNAPSHOT
  • TABLE 94.APOLLO HOSPITALS: OPERATING SEGMENTS
  • TABLE 95.APOLLO HOSPITALS: PRODUCT PORTFOLIO
  • TABLE 96.CARE FERTILITY: COMPANY SNAPSHOT
  • TABLE 97.CARE FERTILITY: PRODUCT PORTFOLIO
  • TABLE 98.CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT
  • TABLE 99.CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO
  • TABLE 100.CITY FERTILITY: COMPANY SNAPSHOT
  • TABLE 101.CITY FERTILITY: PRODUCT PORTFOLIO
  • TABLE 102.FERTILITY ASSOCIATES: COMPANY SNAPSHOT
  • TABLE 103.FERTILITY ASSOCIATES: OPERATING SEGMENTS
  • TABLE 104.FERTILITY ASSOCIATES: PRODUCT PORTFOLIO
  • TABLE 105.GENEA LIMITED: COMPANY SNAPSHOT
  • TABLE 106.GENEA LIMITED: OPERATING SEGMENTS
  • TABLE 107.GENEA LIMITED: PRODUCT PORTFOLIO
  • TABLE 108.MEDICOVER: COMPANY SNAPSHOT
  • TABLE 109.MEDICOVER: OPERATING SEGMENTS
  • TABLE 110.MEDICOVER: PRODUCT PORTFOLIO
  • TABLE 111.MVF: COMPANY SNAPSHOT
  • TABLE 112.MVF: PRODUCT PORTFOLIO
  • TABLE 113.PROGYNY: COMPANY SNAPSHOT
  • TABLE 114.PROGYNY: PRODUCT PORTFOLIO
  • TABLE 115.VIRTUS HEALTH: COMPANY SNAPSHOT
  • TABLE 116.VIRTUS HEALTH: OPERATING SEGMENTS
  • TABLE 117.VIRTUS HEALTH: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.FERTILITY SERVICES MARKET: MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021 (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2021
  • FIGURE 06.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.HIGH THREAT OF SUBSTITUTION
  • FIGURE 09.HIGH THREAT OF NEW ENTRANT
  • FIGURE 10.MODERATE COMPETITIVE RIVALRY
  • FIGURE 11.MARKET DYNAMICS
  • FIGURE 12.APOLLO HOSPITALS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 13.APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 14.MEDICOVER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 15.MEDICOVER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 16.MEDICOVER: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 17.MVF: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 18.MVF: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 19.PROGYNY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 20.PROGYNY: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 21.VIRTUS HEALTH: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 22.VIRTUS HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 23.VIRTUS HEALTH: REVENUE SHARE BY REGION, 2020 (%)